Shire Pharmaceuticals
Former global biopharmaceutical company focused on rare diseases, acquired by Takeda.
Last updated November 4, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Shire Pharmaceuticals was a biopharmaceutical company headquartered in Dublin, Ireland, focused on developing treatments for rare diseases, neuroscience, gastroenterology, and other areas. Founded in 1986, it was listed on NASDAQ and the London Stock Exchange. In 2019, Shire was acquired by Takeda Pharmaceutical Company for approximately $62 billion and integrated into Takeda's operations.
Products and positioning
High-end specialty pharmaceuticals
Cite this profile: Cite the canonical profile. /brand-wiki/shire-pharmaceuticals · Editorial policy · How profiles are compiled